Managed Account Advisors’s Haemonetics HAE Stock Holding History

Managed Account Advisors’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$13M	Buy	313,469 +15,789	+5%	+$666K	0.01%	959
2015 Q1	$13.4M	Buy	297,680 +41	+0%	+$1.71K	0.01%	933
2014 Q4	$11.1M	Buy	297,639 +909	+0.3%	+$33.3K	0.01%	990
2014 Q3	$10.4M	Buy	296,730 +8,039	+3%	+$287K	0.01%	1000
2014 Q2	$10.2M	Buy	288,691 +46,671	+19%	+$1.56M	0.01%	1013
2014 Q1	$7.89M	Buy	242,020 +1,773	+0.7%	+$67.8K	0.01%	1081
2013 Q4	$10.1M	Sell	240,247 -10,769	-4%	-$443K	0.01%	956
2013 Q3	$10M	Buy	251,016 +59,891	+31%	+$2.51M	0.01%	909
2013 Q2	$7.9M	Buy	+191,125	New	+$7.74M	0.01%	983

Other funds holding HAE

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Managed Account Advisors's HAE Position: Q2 2015 in Review

Managed Account Advisors increased its Haemonetics (HAE) stake by 5.3% in Q2 2015, buying an estimated $666K and bringing the position to 313,469 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #959.

Managed Account Advisors first reported a position in HAE in Q2 2013 and has held it in 9 quarters since. The position peaked at $13.4M in Q1 2015. 181 funds tracked by Wall St. Rank hold HAE as of Q2 2015.

Managed Account Advisors held 313,469 shares of Haemonetics worth $13M as of Q2 2015.
Managed Account Advisors bought 15,789 Haemonetics shares in Q2 2015, an estimated $666K.
Haemonetics made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #959 holding.
Managed Account Advisors first reported a position in Haemonetics in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Haemonetics position peaked at $13.4M in Q1 2015.
181 funds tracked by Wall St. Rank held Haemonetics as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.